The company has aggressively reduced total debt from $4.0 billion to $1.5 billion, improving the debt-to-equity ratio to 1.22, but this deleveraging has occurred against a backdrop of stagnant equity and deeply negative retained earnings of -$1.1 billion.
Petco Health and Wellness Company, Inc. (WOOF) balance sheet — 8-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jan'26 | Feb'25 | Feb'24 | Jan'23 | Jan'22 | Jan'21 | Feb'20 | Feb'19 |
|---|
| Total Current Assets | 1.05B | 1.02B | 973.62M | 951.74M | 1.02B | 1.07B | 777.55M | 711M | 761.61M |
| Cash & Short-Term Investments | 293.5M | 256.74M | 165.76M | 125.43M | 201.9M | 211.6M | 111.4M | 148.78M | 180.65M |
| Cash Only | 293.5M | 256.74M | 165.76M | 125.43M | 201.9M | 211.6M | 111.4M | 148.78M | 180.65M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 38.39M | 45.81M | 40.42M | 44.37M | 49.58M | 55.62M | 41.83M | 31.52M | 27.88M |
| Days Sales Outstanding | 2.51 | 2.8 | 2.41 | 2.59 | 3 | 3.5 | 3.1 | 2.59 | 2.32 |
| Inventory | 601.59M | 590.21M | 653.33M | 684.5M | 652.43M | 675.11M | 538.67M | 478.97M | 470.14M |
| Days Inventory Outstanding | 61.06 | 58.92 | 62.89 | 64.04 | 65.99 | 72.89 | 69.88 | 69.15 | 68.99 |
| Other Current Assets | 65.19M | 75.28M | 60.59M | 38.83M | 60.81M | 86.09M | 45.61M | 26.88M | 34.17M |
| Total Non-Current Assets | 4.11B | 4.15B | 4.22B | 4.41B | 5.6B | 5.43B | 5.3B | 5.45B | 4.16B |
| Property, Plant & Equipment | 1.9B | 1.94B | 2.03B | 2.2B | 2.2B | 2.07B | 1.96B | 2.12B | 683.55M |
| Fixed Asset Turnover | 2.54x | 3.07x | 3.02x | 2.84x | 2.74x | 2.81x | 2.52x | 2.10x | 6.43x |
| Goodwill | 980.06M | 980.06M | 980.06M | 980.3M | 2.19B | 2.18B | 2.18B | 2.18B | 2.18B |
| Intangible Assets | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.03B | 1.17B |
| Long-Term Investments | 0 | 0 | 13.95M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 209.67M | 203.83M | 174.02M | 205.69M | 176.81M | 152.79M | 138.19M | 122.39M | 130.93M |
| Total Assets | 5.17B | 5.17B | 5.19B | 5.36B | 6.61B | 6.5B | 6.08B | 6.16B | 4.92B |
| Asset Turnover | 1.16x | 1.15x | 1.18x | 1.17x | 0.91x | 0.89x | 0.81x | 0.72x | 0.89x |
| Asset Growth % | -0.98% | -0.4% | -3.15% | -18.9% | 1.77% | 6.95% | -1.29% | 24.99% | - |
| Total Current Liabilities | 1.17B | 1.13B | 1.14B | 1.11B | 1.02B | 1.05B | 875.31M | 841.94M | 543.47M |
| Accounts Payable | 455.31M | 450.55M | 492.88M | 485.13M | 381.21M | 403.98M | 339.49M | 293.2M | 276.93M |
| Days Payables Outstanding | 45.41 | 44.98 | 47.44 | 45.39 | 38.56 | 43.62 | 44.04 | 42.33 | 40.64 |
| Short-Term Debt | 12.06M | 324.69M | 23.31M | 15.96M | 22.79M | 21.76M | 2.2M | 28.64M | 28.35M |
| Deferred Revenue (Current) | 0 | 0 | 29.56M | 33.52M | 23.05M | 18M | 15.53M | 0 | 0 |
| Other Current Liabilities | 340.64M | 358.9M | 134.15M | 85.3M | 89.93M | 150.63M | 129.48M | 93.69M | 94.27M |
| Current Ratio | 0.90x | 0.90x | 0.85x | 0.86x | 0.99x | 1.02x | 0.89x | 0.84x | 1.40x |
| Quick Ratio | 0.39x | 0.38x | 0.28x | 0.24x | 0.36x | 0.38x | 0.27x | 0.28x | 0.54x |
| Cash Conversion Cycle | 18.16 | 16.75 | 17.86 | 21.24 | 30.43 | 32.77 | 28.94 | 29.42 | 30.67 |
| Total Non-Current Liabilities | 2.79B | 2.88B | 2.94B | 3.07B | 3.21B | 3.19B | 3.15B | 4.75B | 3.74B |
| Long-Term Debt | 1.46B | 1.49B | 1.58B | 1.58B | 1.63B | 1.64B | 1.65B | 3.23B | 3.2B |
| Capital Lease Obligations | 3.08B | 1.05B | 1.05B | 1.12B | 1.17B | 1.12B | 1.1B | 1.16B | 0 |
| Deferred Tax Liabilities | 937.62M | 234.91M | 217.71M | 251.63M | 303.12M | 318.36M | 280.92M | 265.28M | 304.2M |
| Other Non-Current Liabilities | 1.08B | 104.41M | 100.18M | 112.9M | 106.84M | 109.05M | 122.92M | 101.65M | 241.38M |
| Total Liabilities | 3.96B | 4.01B | 4.08B | 4.18B | 4.23B | 4.24B | 4.02B | 5.59B | 4.29B |
| Total Debt | 1.48B | 2.86B | 2.96B | 3.04B | 3.13B | 3.05B | 3B | 4.69B | 3.23B |
| Net Debt | 1.18B | 2.6B | 2.79B | 2.92B | 2.93B | 2.84B | 2.89B | 4.54B | 3.05B |
| Debt / Equity | 1.22x | 2.46x | 2.66x | 2.57x | 1.32x | 1.35x | 1.46x | 8.36x | 5.06x |
| Debt / EBITDA | 4.46x | 9.02x | 14.31x | - | 7.47x | 6.95x | 8.13x | 16.51x | - |
| Net Debt / EBITDA | 3.57x | 8.21x | 13.51x | - | 6.99x | 6.47x | 7.83x | 15.99x | - |
| Interest Coverage | 1.13x | 1.12x | 0.11x | -7.77x | 2.10x | 3.62x | 0.81x | 0.44x | -0.88x |
| Total Equity | 1.21B | 1.16B | 1.11B | 1.18B | 2.38B | 2.26B | 2.06B | 561.06M | 637.91M |
| Equity Growth % | 17.93% | 4.55% | -5.98% | -50.26% | 5.57% | 9.76% | 266.32% | -12.05% | - |
| Book Value per Share | 4.15 | 4.07 | 4.07 | 4.43 | 8.95 | 8.50 | 9.76 | 0.38 | 0.44 |
| Total Shareholders' Equity | 1.21B | 1.16B | 1.11B | 1.18B | 2.38B | 2.27B | 2.07B | 569.39M | 637.91M |
| Common Stock | 286K | 282K | 277K | 269K | 266K | 265K | 264K | 1.36B | 1.35B |
| Retained Earnings | -1.12B | -1.14B | -1.15B | -1.05B | 232.97M | 142.17M | -22.25M | -780.47M | -707.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5.05M | -8.39M | -18.08M | 1.82M | -4.1M | -2.24M | -1.27M | -8.27M | -2.19M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | -18.2M | -13.58M | -8.33M | 0 |
Quick answers to the most common questions about buying WOOF stock.
As of 2025, Petco Health and Wellness Company, Inc. (WOOF) had total assets of $5.17B including $1.02B in current assets.
Petco Health and Wellness Company, Inc. (WOOF) carries total debt of $2.86B, offset by $256.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Petco Health and Wellness Company, Inc. (WOOF) has total shareholders' equity (book value) of $1.16B ($4.07 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Petco Health and Wellness Company, Inc. (WOOF) reported a current ratio of 0.90x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage constrains strategic pivot
Metrics are mathematically derived from official filings.
Leverage Reduction Amidst Stagnant Equity
Petco's balance sheet has shown a notable deleveraging trend, with the debt-to-equity ratio falling from 3.46 in 2025Q3 to 1.22 in 2026Q2, yet this appears driven by debt repayment rather than equity growth, as total equity has remained flat at approximately $1.2 billion.
The sharp reduction in total debt from $4.0 billion to $1.5 billion over three quarters suggests a concerted effort to improve financial flexibility, likely using operating cash flow. However, the lack of corresponding equity growth, with retained earnings deeply negative at -$1.1 billion, indicates this deleveraging is not being funded by profitability but by asset reduction or cash generation, which may limit future investment capacity.
Significant Debt Reduction Improves Profile
Total debt has been aggressively reduced from $4.0 billion in 2025Q3 to $1.5 billion in 2026Q2, a 62.5% decrease that has materially improved the debt-to-equity ratio from 3.46 to 1.22, though the company remains significantly leveraged relative to its equity base.
This rapid deleveraging appears to be a strategic priority, likely aimed at reducing interest expense and refinancing risk in a high-rate environment. The current D/E of 1.22, while improved, still represents a substantial debt burden that may constrain strategic flexibility and limit capital allocation to growth initiatives like the veterinary clinic expansion.
Cash Position Volatile but Improving
Cash on hand has shown significant volatility, ranging from $89.7 million in 2024Q1 to $293.5 million in 2026Q2, while the current ratio has improved from 0.84 to 0.90, suggesting a modest strengthening in short-term liquidity but remaining below the 1.0 threshold that typically indicates full coverage of current liabilities.
The improvement in the current ratio, coupled with the recent cash buildup, suggests better working capital management or debt repayment timing. However, the ratio remaining below 1.0 indicates that current liabilities still exceed current assets, which could pose a liquidity risk if operational cash flow weakens or if there is a sudden need for working capital.
Asset Base Stable with Significant Goodwill
Total assets have remained stable at approximately $5.2 billion, with goodwill constituting a substantial $980.1 million (18.8% of total assets) and property, plant, and equipment net of $1.9 billion, indicating a capital-intensive model with significant intangible value from past acquisitions.
The large goodwill balance represents a potential impairment risk if the company's market position or profitability deteriorates further, as it reflects the premium paid for past acquisitions. The significant PPE base aligns with the company's physical retail and veterinary clinic footprint, confirming the asset-heavy nature of its integrated service model.
Negative Retained Earnings Undermine Equity Quality
Equity quality is significantly impaired by accumulated retained earnings of negative $1.1 billion as of 2026Q2, indicating that historical losses have eroded the company's book value and that current profitability is insufficient to rebuild shareholder equity.
The persistent negative retained earnings suggest that the company has been unable to generate cumulative profits since its formation or since a major recapitalization event. This structural weakness means that the equity base provides a limited cushion against further losses and may restrict the company's ability to return capital to shareholders or fund growth internally.
Debt Reduction May Mask Underlying Weakness
The dramatic reduction in total debt from $4.0 billion to $1.5 billion may be masking underlying operational weakness, as the company's equity base has not grown and retained earnings remain deeply negative, suggesting the deleveraging is achieved through cash generation rather than profitable growth.
While the improved leverage metrics are positive, the source of the cash for debt repayment warrants scrutiny. If the reduction is primarily from operating cash flow rather than asset sales or equity raises, it may indicate that the company is prioritizing balance sheet repair over investment in its growth initiatives, potentially sacrificing long-term competitiveness for short-term financial stability.